HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

Over 2,000 runners were hospitalized and 15 ended up in the ICU during the recent Mumbai Marathon, raising concerns about ...

Parental instincts and quick reaction time led to two Central Illinois parents saving their child’s life.It started at home ...

The salary for EKG technicians, also known as electrocardiograph technicians, varies widely based on several influencing ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

AI reveals hidden patterns in ECGs that human experts can't see, transforming a century-old clinical tool into a powerful ...

Here are three recent recalls reported to the FDA: ...